Drug intelligence / Profile preview

adenosine 5'-[gamma-thio]triphosphate

Development stage
Unknown
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01

Overview

Adenosine 5'-[gamma-thio]triphosphate is a synthetic nucleoside triphosphate analogue of ATP in which one of the oxygens on the terminal (gamma) phosphate group is replaced by sulfur. This modification makes it resistant to hydrolysis by many enzymes, allowing it to act as a non-hydrolyzable or slowly hydrolyzable substitute for ATP in biochemical and physiological studies. It is widely used as a research tool to study processes involving ATP binding and hydrolysis, including kinase reactions (where it yields thiophosphorylated proteins that are resistant to protein phosphatases), purinergic signaling (as an agonist at P2 receptors), modulation of Ca2+-activated K+ channels, and investigations into cell signaling pathways, enzyme kinetics, neurotransmitter release, and proteasome function. It is not approved for clinical use but has broad application in molecular biology, neuroscience research, and drug development[1][2][4].

Other names
adenosine 5'-[γ-thio]triphosphateadenosine 5'-(3-thiotriphosphate)adenosine 5'-O-(3-thiotriphosphate)adenosine 5'-(gamma-S)triphosphateAdo-5'-PPP[S]adenosine 5'-thiotriphosphate
02

Targets

PK (Pyruvate kinase)P2RY2 (P2Y Purinoceptor 2)P2RY11 (Purinergic receptor P2Y11)

Beyond the preview

Go deeper on adenosine 5'-[gamma-thio]triphosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on adenosine 5'-[gamma-thio]triphosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call